KENNETH REAY CODE - 31 Dec 2024 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director
Signature
/s/ John R. Browning, attorney-in-fact
Issuer symbol
BLGO
Transactions as of
31 Dec 2024
Net transactions value
+$10,957
Form type
4
Filing time
03 Jan 2025, 18:40:23 UTC
Previous filing
03 Jan 2024
Next filing
16 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common stock Award $10,957 +57,666 +0.23% $0.1900 25,120,245 31 Dec 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.